Clinical Trial Update: TMC435-TiDP16-C121: A Study Comparing 2 Tablet Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Effect of Food on Blood Levels of TMC435 [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing two tablet formulations of TMC435 to an established capsule formulation and evaluating the effect of food on blood levels of TMC435 ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TMC435

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C Virus | Phase 1 | Status: COMPLETED